Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
Frequently Asked Questions
What is Market Cap of Foamix Pharmaceuticals Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Foamix Pharmaceuticals Ltd market cap is N/A.
What is the 52-week high for Foamix Pharmaceuticals Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Foamix Pharmaceuticals Ltd 52 week high is N/A as of September 09, 2025.
What is the 52-week low for Foamix Pharmaceuticals Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Foamix Pharmaceuticals Ltd 52 week low is N/A as of September 09, 2025.
What is Foamix Pharmaceuticals Ltd stock price today?
Foamix Pharmaceuticals Ltd stock price today is $2.99.
What was Foamix Pharmaceuticals Ltd stock price yesterday?
Foamix Pharmaceuticals Ltd stock price yesterday was $3.24.
What is the PE ratio of Foamix Pharmaceuticals Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Foamix Pharmaceuticals Ltd’s P/E ratio is None.
What is the Price-to-Book ratio of Foamix Pharmaceuticals Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Foamix Pharmaceuticals Ltd P/B ratio is None.
What is Foamix Pharmaceuticals Ltd's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Foamix Pharmaceuticals Ltd's EBITDA is -1.74.
What is the 50-day moving average of Foamix Pharmaceuticals Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Foamix Pharmaceuticals Ltd 50-day moving average is N/A.
How many employess does Foamix Pharmaceuticals Ltd has?